The relationship between the cycle threshold value of SARS CoV-2 with neutrophil lymphocyte ratio (NLR), absolute lymphocyte count (ALC), severity degrees, long of treatment, and outcomes COVID-19 patients

Author:

Aina Nurlaila ,Mohamad Isa ,Rahmiati Lao ,Ira Nurrasyidah ,Isa Ansori ,Erna Kusumawardhani

Abstract

Link of Video Abstract: https://youtu.be/uGfZNQrEQqY   Background: Coronavirus disease 2019 (COVID-19) has caused serious public health problems since the end of 2019. Viral load is known in COVID-19 infection, which indicates the number of causative agents and is indirectly assessed by the Cycle threshold value (Ct value). Ct value assessment has not been declared an essential parameter in COVID-19 infection. Due to the high number of COVID-19 cases, an additional strategy is needed to help identify patients at high risk of experiencing severe clinical conditions by knowing the relationship between the Ct value of SARS CoV-2 and neutrophil lymphocyte ratio (NLR), absolute lymphocyte count (ALC), severity, length of stay, and outcomes. Methods: This was an analytic observational study with cross-sectional approach in confirmed COVID-19 patients to investigate the relationship between the Ct value of SARS CoV-2 and NLR, ALC, severity, length of stay, and outcome of COVID-19 patients. There were 337 patients analyzed with chi square test. Results: The results of this study indicate that the majority of subjects were male (51%), aged <60 years (27%), Ct value ≤29 (70%), had a critical severity (36.5%), length of stay >10 days (64.1%) and survived (74.7%). Inflammatory markers examination shows NLR<3,13 (57.9%) and ALC<1500 (66.2%). The chi-square test shows a significant relationship between Ct value and ALC, degree of severity, and outcome in COVID-19 patients (p <0.05). No association was found between Ct value, NLR, and length of stay (p>0.05). Conclusion: There is a relationship between Ct value and ALC, degree of severity, and outcome in COVID-19 patients.

Publisher

DiscoverSys, Inc.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3